Diagnomics debuts cardiovascular health panel

By LabPulse.com staff writers

October 8, 2019 -- San Diego-based genetic testing laboratory Diagnomics is introducing a cardiovascular health report for use on the Illumina Global Screening Array platform.

The Gene Impetus - Cardiac Care report will tap into information on more than 110 genes underlying more than 30 cardiovascular conditions, such as cardiomyopathies, high cholesterol, and arrythmias, according to the company.

Diagnomics noted that the cardiovascular panel is part of its College of American Pathologists (CAP)/CLIA product line, which focuses on personalized medicine and medically actionable information that aid in disease prevention.

Genotyping spares bleeding with cardiovascular drugs
Genotype-guided treatment meant less bleeding for some patients who underwent primary percutaneous coronary intervention and were taking blood thinners...
Cardiologists back more screening, tight LDL and glucose control
Researchers made a strong call for genetic screening for heterozygous familial hypercholesterolemia at the European Society of Cardiology and World Congress...
Ortho's Vitros BNP assay gets CE Mark
Ortho Clinical Diagnostics' Vitros N-terminal pro b-type natriuretic peptide (NT-proBNP) assay for diagnosing and assessing risk for cardiovascular events,...
How to use troponin tests in the ER
Experience with a risk assessment tool that guides the use of high-sensitivity troponin blood tests to help show whether emergency room (ER) patients...
Panel blood test beats gold standard BNP in heart failure
Simultaneously testing 25 biomarkers including the commonly measured B-type natriuretic peptide (BNP) using a small amount of blood looks promising for...

Copyright © 2019 LabPulse.com

Last Updated np 10/8/2019 10:54:46 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.